The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
NCT01985620 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2014-06-26
Summary
Premature infants (born before 34 wk) are routinely vaccinated against RSV but vaccination rate against influenza are low in spite of national programs. Study goal is to evaluate the effectiveness of short intervention during RSV prophylaxis visit, planned to educate parents about the importance of influenza vaccination.
Conditions
- Prematurity
- RSV
- Influenza
- Upper Respiratory Tract Infection
- Lower Respiratory Tract Infection
Interventions
- BEHAVIORAL
-
Educational intervention
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2015-04-30
Countries
- Israel
Study Locations
More Related Trials
-
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
NCT01467934 ·Status: COMPLETED
-
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children
NCT00391391 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above
NCT04841577 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine in HIV Infected Children
NCT00883012 ·Status: COMPLETED ·Phase: PHASE4
-
Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age
NCT00231920 ·Status: COMPLETED ·Phase: PHASE1
-
Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
NCT07310472 ·Status: RECRUITING ·Phase: NA
-
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
NCT00812110 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Explanation Given to Parents on Rate of Post-partum Influenza Vaccination
NCT03053674 ·Status: UNKNOWN ·Phase: NA
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants
NCT01494740 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
NCT00844051 ·Status: COMPLETED ·Phase: NA
-
Comparison of Flu Vaccine Doses in Children
NCT01164553 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
NCT04732871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
NCT00644540 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
NCT02035696 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above
NCT05568797 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population
NCT00700193 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
NCT01246999 ·Status: COMPLETED ·Phase: PHASE4
-
Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
NCT02358083 ·Status: COMPLETED ·Phase: NA
-
A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above
NCT05059301 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
NCT00242424 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity
NCT00710866 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
NCT00980005 ·Status: COMPLETED ·Phase: PHASE3
-
Inactivated Influenza Vaccine Effectiveness in Tropical Africa
NCT00893906 ·Status: COMPLETED ·Phase: PHASE4